Preventing HIV infection: pre-exposure and postexposure prophylaxis - Wikidata - awgldk - TriplyDB

Preventing HIV infection: pre-exposure and postexposure prophylaxis

Preventing HIV infection: pre-exposure and postexposure prophylaxis

http://www.wikidata.org/entity/Q26828445

about

Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis The Price of Prevention: Cost Effectiveness of Biomedical HIV Prevention Strategies in South Africa

P2860

Q55338133-E3AFD563-D9F3-4EF1-9530-6CE3FC934626 Q56794669-FE3C564E-42E1-4978-9BA3-09880DCC6806 Q56910975-28A125EB-EF45-4939-A3F5-9213F44B247D

P2860

Preventing HIV infection: pre-exposure and postexposure prophylaxis

http://www.wikidata.org/entity/Q26828445

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@ast

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@en

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@nl

type

label

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@ast

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@en

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@nl

prefLabel

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@ast

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@en

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@nl

P1433

Q26828445-9FC5D7E1-DB07-4C95-B73F-BEC97B4FBE8D

P1476

Q26828445-57FC1585-9FC1-4D05-9687-53D39F9C090A

P2093

Q26828445-5210C3E2-94BD-43B0-8F7B-E3F36B38877F

Q26828445-EBEBC521-E31D-4EE8-B369-2DEDBACD336E

P2860

Q26828445-07D67579-AA94-4AF7-BD7A-509F6B908828

Q26828445-08FC30BE-D058-4A71-9B50-1D5B83FEB42B

Q26828445-0A7ABE88-0717-4479-B59D-CBCF3DF719C1

Q26828445-0AEE1782-11BD-42B9-9AB2-EDA422E47A26

Q26828445-0B09F7FD-50CE-4D49-8D29-722A1CB0CF29

Q26828445-0B91EFE8-B9F2-49BE-9E99-ADE496694FF4

Q26828445-0ECC5774-935D-44F6-A142-A34363D33FCB

Q26828445-10E4EEB0-E9ED-415F-B3C2-D8B5502DED66

Q26828445-132A6154-D95A-4144-A17E-62142BC75CB5

Q26828445-19BBD928-683A-412B-81B4-5B7158917EF9

P304

Q26828445-94C089A1-857A-41C8-8B45-5CDAE4D41035

P31

Q26828445-F424C5FE-A247-49B9-A11A-F8C522254428

P356

Q26828445-FEB10CA0-1B8C-4288-B760-62815C860AF0

P407

Q26828445-B7F7FBB8-DDB8-4BE4-8700-7EF0D8A65BBC

P433

Q26828445-98FD7313-1B80-4568-A7E6-902E8B028FE9

P478

Q26828445-D38BE9C9-9B8F-4BCA-8F43-5510D9EC2F19

P577

Q26828445-72805B1D-AD9A-4778-981E-8A98EDBC6FB3

P698

Q26828445-99CE02DD-ED04-45F0-85BC-4BB19694A714

P356

P1433

P1476

Preventing HIV infection: pre-exposure and postexposure prophylaxis

@en

P2093

Michael A. Kolber

http://www.w3.org/2001/XMLSchema#string

Susanne Doblecki-Lewis

http://www.w3.org/2001/XMLSchema#string

P2860

Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

Prevention of HIV-1 infection with early antiretroviral therapy

Preexposure prophylaxis for HIV prevention: where have we been and where are we going?

Antiretroviral pharmacology in mucosal tissues

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

Antiretroviral prophylaxis for HIV prevention in heterosexual men and women

Global epidemiology of HIV infection in men who have sex with men

Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

P304

453-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IUB.1286

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24975125

http://www.w3.org/2001/XMLSchema#string